Aviation, Space, and Environmental Medicine

Computational model of sustained acceleration effects on human cognitive performance.


PMID 23926652

Abstract

Extreme acceleration maneuvers encountered in modern agile fighter aircraft can wreak havoc on human physiology, thereby significantly influencing cognitive task performance. As oxygen content declines under acceleration stress, the activity of high order cortical tissue reduces to ensure sufficient metabolic resources are available for critical life-sustaining autonomic functions. Consequently, cognitive abilities reliant on these affected areas suffer significant performance degradations. The goal was to develop and validate a model capable of predicting human cognitive performance under acceleration stress.Development began with creation of a proportional control cardiovascular model that produced predictions of several hemodynamic parameters, including eye-level blood pressure and regional cerebral oxygen saturation (rSo2). An algorithm was derived to relate changes in rSo2 within specific brain structures to performance on cognitive tasks that require engagement of different brain areas. Data from the "precision timing" experiment were then used to validate the model predicting cognitive performance as a function of G(z) profile.The following are value ranges. Results showed high agreement between the measured and predicted values for the rSo2 (correlation coefficient: 0.7483-0.8687; linear best-fit slope: 0.5760-0.9484; mean percent error: 0.75-3.33) and cognitive performance models (motion inference task--correlation coefficient: 0.7103-0.9451; linear best-fit slope: 0.7416-0.9144; mean percent error: 6.35-38.21; precision timing task--correlation coefficient: 0.6856-0.9726; linear best-fit slope: 0.5795-1.027; mean percent error: 6.30-17.28).The evidence suggests that the model is capable of accurately predicting cognitive performance of simplistic tasks under high acceleration stress.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

47829
D-(+) Glucose, analytical standard
C6H12O6
G7528
D-(+)-Glucose, BioXtra, ≥99.5% (GC)
C6H12O6
G8270
D-(+)-Glucose, ≥99.5% (GC)
C6H12O6
G5767
D-(+)-Glucose, ACS reagent
C6H12O6
G5400
D-(+)-Glucose, ≥99% (GC)
C6H12O6
G6152
D-(+)-Glucose, suitable for mouse embryo, ≥99.5% (GC)
C6H12O6
G5146
D-(+)-Glucose, Hybri-Max, powder, BioReagent, suitable for hybridoma
C6H12O6
G7520
D-(+)-Glucose, plant cell culture tested, BioReagent
C6H12O6
49139
D-(+)-Glucose, BioUltra, anhydrous, ≥99.5% (sum of enantiomers, HPLC)
C6H12O6
49152
D-(+)-Glucose, Ph Eur, anhydrous
C6H12O6
608203
D-(+)-Glucose, 99.9 atom % 16O, 99.9 atom % 12C
C6H12O6
47249
D-(+)-Glucose, analytical standard
C6H12O6
G8769
D-(+)-Glucose solution, 45% in H2O, sterile-filtered, BioXtra, suitable for cell culture
C6H12O6
G8644
D-(+)-Glucose solution, 100 g/L in H2O, sterile-filtered, BioXtra, suitable for cell culture
C6H12O6
G3285
D-(+)-Glucose solution, 1 mg/mL in 0.1% benzoic acid, standard for enzymatic assay kits GAGO20, GAHK20, STA20, analytical standard
C6H12O6
D9434
Dextrose, meets EP, BP, JP, USP testing specifications, anhydrous
C6H12O6
295604
Oxygen, ≥99.6%
O2

Set your institution to read full text papers when available.